News
A start-up that launched only 8 months ago has attracted the attention of Biogen, a major developer of neurological drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback